Gordon Research Conference on the IGF & insulin system in Physiology & Disease
17 January 2019
GroPep Bioreagents is proud to support the Gordon Research Conference on the IGF & insulin system in Physiology & Disease in March 2019
GroPep Bioreagents is proud to support the Gordon Research Conference on the IGF & insulin system in Physiology & Disease in March 2019
Human IGFBP-2 has been reintroduced to the GroPep Bioreagents product portfolio
Let us know if you have a favourite Company that you would like to supply you with our products. We will try and add them to the list.
GroPep Bioreagents is pleased to announce that the Company has achieved Certification of Compliance to AS/NZS ISO 9001:2016 Quality Management System
GroPep’s range of growth factors, analogues, antibodies and binding proteins
Human LR³ insulin-like Growth Factor-I (LR³IGF-I) was developed by GroPep Bioreagents specifically for supplementation of mammalian cell culture to support the survival and proliferation of cells. This LR³IGF-I Rapid™ ELISA kit combines GroPep’s expertise in the field of IGF research and Biosensis’ newly established Rapid™ ELISA platform.
GroPep Bioreagents is pleased to announce a partnership with Biosensis to jointly develop and market ELISA kits using GroPep’s experience in the IGF field and Biosensis’ Rapid ELISA platform.
Use our pre-tested reagents (BK-MAN-MAO) or Develop the assay ‘in house’ using our monoclonal antibodies MAN100 and MAO100
GroPep Bioreagents welcomes BeiJing Biolead Biology Sci & Tech. Co. Ltd. as a partner for GroPep Bioreagents’ product range.
GroPep Bioreagents will attend the 7th International Congress of the GRS and IGF Society in Singapore, 15 – 18 October 2014. We are a Silver Sponsor of the meeting.
Hope you enjoyed the meeting. Looking forward to 2016.